Skip to content

The Bidirectional, Single-Center, Real-World Clinical Study on the Effects of Chemotherapy and Chemotherapy Combined with Immune Therapy on Serum NETS Expression and T Cell Activity in Gastric Cancer Patients

The Bidirectional, Single-Center, Real-World Clinical Study on the Effects of Chemotherapy and Chemotherapy Combined with Immune Therapy on Serum NETS Expression and T Cell Activity in Gastric Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097630
Enrollment
Unknown
Registered
2025-02-22
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Chemotherapy + Immunotherapy (The treatment is carried out using standardized chemotherapy combined with immune therapy):None

Sponsors

Renji Hospital ,Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily participate in this study and sign an informed consent form. 2. Age between 18 and 80 years, both males and females are eligible. 3. Patients must have a histologically confirmed diagnosis of untreated gastric cancer or gastroesophageal junction (GEJ) cancer, with histological examination confirming that it is primarily adenocarcinoma (TNM staging, 8th UICC/AJCC).

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women. 2. Women of childbearing age with a positive pregnancy test at baseline.

Design outcomes

Primary

MeasureTime frame
Neutrophil Extracellular Traps;T cell activity;

Countries

China

Contacts

Public ContactZizhen Zhang; Xiang Xia

Renji Hospital, Shanghai Jiao Tong University School of Medicine

zzzhang16@hotmail.com+86 139 1787 9569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026